Page last updated: 2024-08-21

pyrazines and losartan

pyrazines has been researched along with losartan in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berg, T1
Tang, X1
Lam, SY; Leung, KK; Leung, PS; Liang, J1
Arafat, T; Idkaidek, N1

Trials

1 trial(s) available for pyrazines and losartan

ArticleYear
[Effect of ligustrazine on proliferative glomerulonephritis].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2003, Volume: 26, Issue:8

    Topics: Adolescent; Adult; Creatinine; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Losartan; Male; Middle Aged; Prednisone; Pyrazines; Serum Albumin

2003

Other Studies

3 other study(ies) available for pyrazines and losartan

ArticleYear
The vascular response to the K+ channel inhibitor 4-aminopyridine in hypertensive rats.
    European journal of pharmacology, 2003, Apr-18, Volume: 466, Issue:3

    Topics: 4-Aminopyridine; Adrenalectomy; Adrenergic Antagonists; Amifampridine; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Indomethacin; Losartan; Male; Muscarinic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phentolamine; Potassium Channel Blockers; Prazosin; Protein Kinase C; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Staurosporine; Sulfonamides; Vascular Resistance; Vasoconstriction

2003
Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells.
    Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:9

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Humans; Islets of Langerhans; Losartan; Male; Mice; Pyrazines; Regeneration; Sitagliptin Phosphate; Stem Cells; Triazoles

2012
Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system.
    Molecular pharmaceutics, 2012, Aug-06, Volume: 9, Issue:8

    Topics: Acetates; Anthraquinones; Azithromycin; Benzhydryl Compounds; Cinacalcet; Cloxacillin; Cresols; Cyclopropanes; Female; Fluorobenzenes; Humans; Hydrochlorothiazide; Losartan; Male; Metformin; Naphthalenes; Phenylpropanolamine; Piroxicam; Pyrazines; Pyrimidines; Quinolines; Rosuvastatin Calcium; Saliva; Sitagliptin Phosphate; Sulfides; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Triazoles

2012